Vir Biotechnology is now a two-engine company, with major pharma partnerships and a fully enrolled hepatitis delta phase 3 ...

Nautilus Biotechnology Inc. stocks have been trading up by 12.74 percent amid bullish sentiment from its latest breakthrough ...

Healthcare stocks underperformed the broader market in September, with the Health Care Select Sector SPDR Fund (XLV) falling ...

Vir Biotechnology has appointed Aziz Sawaf as Executive Vice President and Chief Financial Officer, effective October 5, 2026 ...

Novonesis has completed its acquisition of Australian biotechnology company MicroBioGen, strengthening its expertise in yeast ...

Inmunova’s pioneering drug could become the first specific treatment for a disease that mainly affects children ...

(Nasdaq: VIR) today announced the appointment of Aziz Sawaf, MBEE, MBA, CFA, as Executive Vice President and Chief Financial ...

Nautilus Biotechnology Inc. stocks have been trading up by 15.14 percent amid heightened investor optimism from its latest ...

Inhibrx Biosciences' CEO bought $3.6 million in shares after strong Phase 2 data, as insiders accumulate stock amid heavy short interest and an upcoming FDA decision on ozekibart.

Spiber Inc., a bio-venture from Tsuruoka City, Yamagata Prefecture, is garnering significant attention as an innovation in ...

Research and Markets has opened registration for the live online course, Protein Engineering for Pharmaceutical Biotechnology, organized by IPI Academy and taking place February 2-3, 2027, equipping ...